C07J - Steroids - Patents Sitemap

More topics under "C07J - Steroids" (42,482)
C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828)
C07J 11 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 3 (283)
C07J 13 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having a carbon-to-carbon double bond from or to position 17 (764)
C07J 15 - Stereochemically pure steroids containing carbon, hydrogen, halogen, or oxygen, having a partially or totally inverted skeleton, e.g. retrosteroids, l-isomers (136)
C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111)
C07J 19 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 by a lactone ring (362)
C07J 21 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton (1,576)
C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033)
C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027)
C07J 33 - Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (413)
C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637)
C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516)
C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937)
C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565)
C07J 53 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms (1,809)
C07J 61 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms (90)
C07J 63 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms (2,707)
C07J 65 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of two rings, each by one atom (2)
C07J 67 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of two rings, each by one atom (2)
C07J 69 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one atom and expansion of only one ring by one atom (107)
C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018)
C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845)
C07J 73 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms (1,160)
C07J 75 - Processes for the preparation of steroids, in general (1,657)
C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897)

Patents for C07J - Steroids (408)
06/2014
06/24/2014	US8759304 Compositions and methods for increasing telomerase activity
05/2014
05/22/2014	US20140142077 Androgen pharmaceutical composition and method for treating depression
09/2013
09/17/2013	US8536156 Contraception process and administration form for the same
08/2013
08/14/2013	CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof
01/2013
01/23/2013	EP2548880A2 Compositions for increasing telomerase activity
12/2012
12/18/2012	CA2519956C Compound
10/2012
10/17/2012	CN102727501A Uses of sapogenins and their derivatives
09/2012
09/27/2012	US20120245134 Androgen pharmaceutical composition and method for treating depression
09/12/2012	EP2497776A2 Process for the production of tibolone
08/2012
08/01/2012	EP1761484B1 Method of improving the crushing strength and reducing the dust formation and the caking tendency of urea, and urea composition
05/2012
05/30/2012	CN1642558B Uses of sapogenins and their derivatives
05/24/2012	US20120129823 Contraception process and administration form for the same
04/2012
04/10/2012	CA2528483C Compositions and methods for increasing telomerase activity
03/2012
03/15/2012	US20120065180 Androgen pharmaceutical composition and method for treating depression
03/08/2012	US20120058981 Androgen pharmaceutical composition and method for treating depression
12/2011
12/15/2011	US20110306582 Androgen pharmaceutical composition and method for treating depression
12/13/2011	US8076317 administering contraceptives comprising hormones in cycles
10/2011
10/25/2011	US8044223 Crystalline 19-norsteroids
08/2011
08/23/2011	US8003783 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer
08/09/2011	CA2569715C Method of improving the crushing strength and reducing the dust formation and the caking tendency of urea, and urea composition
08/04/2011	US20110190249 Therapeutic methods and uses of sapogenins and their derivatives
06/2011
06/22/2011	EP2336146A1 17beta-hydroxysteroid dehydrogenase inhibitors
03/2011
03/24/2011	US20110071095 Compositions and Methods for Increasing Telomerase Activity
02/2011
02/23/2011	EP1070725B9 Solid dispersion containing sialic acid derivative
02/08/2011	US7884222 Process for the production of tibolone
01/2011
01/26/2011	CN1972906B Method of improving the crushing strength and reducing the dust formation and the caking tendency of urea, and urea composition
01/18/2011	US7872135 Method for introducing a 1,2-double bond into 3-oxo-4-azasteroid compounds
12/2010
12/14/2010	CA2420292C Contraception process and administration form for the same
12/07/2010	US7846904 Compositions and methods for increasing telomerase activity
10/2010
10/19/2010	US7816561 Method of improving the crushing strength and reducing the dust formation and the caking tendency of urea, and urea composition
06/2010
06/16/2010	CN1809364B Compositions and methods for increasing telomerase activity
04/2010
04/13/2010	CA2102112C A substance for lowering high cholesterol level in serum and a method for preparing the same
04/06/2010	US7691834 Substance for lowering high cholesterol level in serum and methods for preparing and using the same
03/2010
03/11/2010	US20100062023 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
02/2010
02/24/2010	CN101654470A Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof
02/23/2010	US7666846 a conjugate of chloesterol containing compound having a sugar moiety containing methyl esteralkyleneazide group and a carrier protein; produce an effective vaccine to prevent Lyme disease
02/17/2010	EP2153849A2 Contraception process and administration form for the same
12/2009
12/24/2009	US20090318398 Androgen pharmaceutical composition and method for treating depression
12/08/2009	US7629335 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour
11/2009
11/18/2009	CN100560132C Contraception process and administration for same
11/11/2009	EP1317286B1 Administration form for hormonal contraception
08/2009
08/12/2009	CN100526328C 17beta-hydroxysteroid dehydrogenase inhibitors.
07/2009
07/29/2009	CN101492487A Process to prepare eplerenone
06/2009
06/18/2009	US20090156567 Novel anti-inflammatory androstane derivative
05/2009
05/12/2009	US7531528 mixture of aqueous carrier liquid containing dissolved glucocorticoid and 3-oxoandrostane carbothioic coompound
03/2009
03/04/2009	EP2030979A1 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
02/2009
02/10/2009	CA2429574C Sterilisation of pharmaceuticals
01/2009
01/14/2009	EP1613641B1 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
09/2008
09/24/2008	CN100420699C Process for the production of tibolone
08/2008
08/26/2008	CA2333669C 17.beta.-amino and hydroxylamino-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
08/13/2008	CN101239090A Pharmaceutical compositions having appetite suppressant activity
08/13/2008	CN101239089A Pharmaceutical compositions having appetite suppressant activity
07/2008
07/17/2008	US20080171034 2-Adamantyl-3-hydroxycyclopenta[a]phenanthren-17-yldeneimino-oxy, -amino- and -aminocarbonyl compounds; degenerative diseases including neurodegenerative; ophthalmic; cardiovascular; bone, joint, connective tissue or cartilage; & mitochondrial disorders; transplants; altered activity of excitotoxic path
06/2008
06/11/2008	CN101195649A Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
06/03/2008	CA2467964C Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances
05/2008
05/20/2008	US7375098 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes
05/15/2008	US20080113925 Compositions and Methods for Increasing Telomerase Activity
04/2008
04/16/2008	CN100381457C 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos
04/08/2008	CA2305764C Bile acid salts of metals with physiological action and the use thereof in therapy
04/02/2008	CN100378118C Pharmaceutical compositions having appetite suppressant activity
02/2008
02/21/2008	US20080041131 Method of Improving the Crushing Strength and Reducing the Dust Formation and the Caking Tendency of Urea, and Urea Composition
01/2008
01/08/2008	CA2196690C Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function
12/2007
12/26/2007	CN100357311C 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
12/18/2007	CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer
12/04/2007	US7304171 Compounds and methods for cytoprotection
11/2007
11/28/2007	CN100351265C Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
11/22/2007	US20070270584 Process for the Preparation of Steroidal Carbothioic Acid Derivatives and Intermediates
11/20/2007	US7297801 Process for the production of 2-oxa-3-one androstane derivatives
09/2007
09/18/2007	CA2236648C Sulfatation of estrogen mixtures
07/2007
07/10/2007	CA2283564C Pharmaceutical compositions having appetite suppressant activity
06/2007
06/06/2007	CN1319985C Method for introducing a 1,2 double bond into 3-oxo-4-azasteroid compounds
05/2007
05/30/2007	CN1972906A Method of improving the crushing strength and reducing the dust formation and the caking tendency of urea, and urea composition
04/2007
04/24/2007	CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives
04/17/2007	US7205287 Platinum complexes having antitumor activity
03/2007
03/29/2007	US20070072835 Method of preparing and use of prodrugs of betulinic acid derivatives
03/14/2007	EP1761484A1 Method of improving the crushing strength and reducing the dust formation and the caking tendency of urea, and urea composition
02/2007
02/07/2007	EP1749017A2 Compounds and methods for cytoprotection
02/01/2007	US20070027128 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour
01/2007
01/23/2007	US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction
12/2006
12/05/2006	US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/2006
11/23/2006	US20060264412 Carbonylation; hydrogenation; for preparation of eplerenone
11/07/2006	US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/02/2006	EP0973534B1 Plant extracts having appetite suppressant activity
10/2006
10/24/2006	US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
09/2006
09/27/2006	CN1839145A Steroid spirolactonization
09/27/2006	CN1837231A Immunomodulatory steroids, in particular the hemihydrate of 16, alpha-bromoepiandrosterone
09/14/2006	US20060205931 Pharmaceutical compositions having appetite suppressant activity
09/14/2006	US20060204515 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
09/06/2006	EP1453520B1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances
08/2006
08/22/2006	CA2328085C Solid dispersion containing sialic acid derivative
08/15/2006	US7091195 Derived from plants; for preventing or inhibiting tumor growth
08/03/2006	US20060173201 Process for the produciton of tibolone
07/2006
07/26/2006	CN1809364A Compositions and methods for increasing telomerase activity
07/19/2006	EP1082337B1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
06/2006
06/21/2006	EP1337279B1 Sterilisation of glucocorticosteriode suspensions
06/21/2006	CN1791611A 17beta-hydroxysteroid dehydrogenase inhibitors.
06/08/2006	WO2004085458A9 Steroid spirolactonization
05/2006
05/31/2006	CN1780849A Process for the production of tibolone
05/24/2006	CN1777618A 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos
05/11/2006	US20060100434 dehydrogenating 17 beta -substituted 3-oxo-4-azasteroids to prepare the corresponding 17 beta -substituted 3-oxo-4-azasteroids which have a double bond in the 1,2-position

1 2 3 4 5